Resultados de la búsqueda 811-820 of 15007 for Guillain-Barre Syndrome

  1. Síndrome urémico hemolítico (SUH) - Síntomas y causas - Mayo Clinic

    Hemolytic uremic syndrome. Pediatric Clinics of North America. 2019; doi:10.1016/j.pcl.2018.09.011. Soliris (eculizumab) prescribing information. Alexion ...

  2. Ensayos clínicos - Neurología

    The purpose of this study is to understand how electrical stimulation of the brain can modulate and suppress interictal epileptiform activity as a step on the ...

  3. Centros vasculares - Ensayos clínicos

    Spontaneous coronary artery dissection (SCAD) is uncommon but important cause of acute coronary syndrome and sudden cardiac death. There is very little data ...

  4. Neurología - Ensayos clínicos

    The goal of this research is to investigate the hypothesis that this presentation represents a spatially limited form of CNS inflammatory demyelinating disease.

  5. Ensayos clínicos - Neurología

    The purpose of the study is to learn more about inflammatory diseases of the central nervous system (CNS) by collecting patient information, blood sample (which ...

  6. Síndrome de dolor regional complejo - Diagnóstico y tratamiento - Mayo Clinic

    Qué esperar del médico · AskMayoExpert. Complex regional pain syndrome. Mayo Clinic; 2021. · Medical review (expert opinion). Mayo Clinic. Jan. 12, 2022.

  7. Ensayos clínicos - Hematología

    Jacksonville, Fla. The purpose of phase 2a is to establish proof-of-concept (POC) for AG-946 in participants with lower-risk myelodysplastic syndromes ...

  8. Ensayos clínicos - Neurología

    Rochester, Minn. The purpose of this study is to develop prognostic and diagnostic blood tests for symptomatic brain hemorrhage in patients diagnosed with ...

  9. Accidente cerebrovascular - Médicos y departamentos - Mayo Clinic

    neurólogo. Rochester, MN. Áreas de desarrollo: Accidente cerebrovascular, Síndrome de Guillain Barré, Hemorragia subaracnoidea, Infarto cerebral isquémico ...

  10. Ensayos clínicos - Neurología

    ... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke. A ...